Kaplan–Meier survival analysis of HNSCC cohort based on protein expression has validated the findings from the genomic dataset, which suggests EGFR-MEK-ERK cascade proteins could predict HNSCC patient survival as a prognostic signature (Fig. 5d). The gene discussed is MAP2K7; the disease is head and neck squamous cell carcinoma.